Stifel analyst Selman Akyol raised the firm’s price target on Global Partners (GLP) to $54 from $51 and keeps a Buy rating on the shares.

Europe’s high grade corporate bond market hosted a blowout day for borrowers, as peak orders for Volkswagen Financial ...

FGS Global, which grew into one of the world’s biggest corporate communications firms through a series of mergers, has hired ...

Stifel Nicolaus analyst Selman Akyol maintained a Buy rating on Global Partners (GLP – Research Report) today and set a price target of $54.00. The company’s shares closed yesterday at $49.27.

Marketa Dvorak was appointed managing director for the global financial institutions team in Asia-Pacific at the $2.8 trillion Capital Group, the firm said in a statement on Nov. 12. She continues to ...

Here are some of the biggest names on the VCsForKamala list and other leading corporate leaders backing ... the managing director at Insight Partners, a global venture capital and private equity ...

QatarEnergy will partner with French TotalEnergy on a solar power project in Iraq, part of a larger energy project planned by the supermajor. The two will have equal shares in the enterprise ...

Mikel Arteta and members of our first team, including Jurrien Timber, David Raya, Martin Odegaard and Kai Havertz attended Monday night’s Global Gift Gala. Former Gunner David Seaman was also in ...

Dean of Trinity Business School We are pleased to announce our partnership with the Trinity Corporate Governance Lab as its legal knowledge partner. The Corporate Governance Lab, an initiative of the ...

In South-east Asia, it now wants to be more than just that. Richard Yorke, head of global corporate and investment banking for Asia-Pacific at MUFG, noted that it is also a significant shareholder of ...

Global corporate VC investment fell from $54 billion to $35.2 billion ... but market conditions are improving," said Francois Chadwick, Partner, KPMG in the US. "With interest rates dropping, M&A will ...

Bright Minds Biosciences Inc, headquartered in the USA, was founded on March 8, 2021. The company is at the forefront of developing innovative treatments for neuropsychiatric disorders, epilepsy ...